| Issue | Title | |
| Vol 16, No 5 (2009) | 131-Iodine Tositumomab in lymphoma | Abstract PDF |
| M.C. Cheung, J.A. MacEachern, A.E. Haynes, R.M. Meyer, K. Imrie, and the Members of the Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care | ||
| Vol 19, No 1 (2012) | A call for action in survivorship research and care | Abstract PDF HTML |
| R. Doll, A. Kazanjian, K. Smillie, A. Ward, M. Chasen | ||
| Vol 18, No 2 (2011) | A Canadian economic analysis of U.S. Oncology Adjuvant Trial 9735 | Abstract PDF HTML |
| L. Bernard, S. Verma, M. F. Thompson, B. C.F. Chan, N. Mittmann, L. Asma, S. E. Jones | ||
| Vol 17, No 4 (2010) | A case for tobacco content regulation by the U.S. Food and Drug Administration | Abstract PDF |
| J.A. du Toit | ||
| Vol 18, No 1 (2011) | A comparative analysis of monthly out-of-pocket costs for patients with breast cancer as compared with other common cancers in Ontario, Canada | Abstract PDF HTML |
| C. J. Longo, B. G. Bereza | ||
| Vol 13, No 2 (2006) | A Comparison of the Sensitivity of Intensity Modulated and Three-Dimensional Conformal Radiation Therapy Plans for Oropharyngeal Cancer to Set-Up Errors and Uncertainties | Details PDF |
| Nicolas Paul Ploquin | ||
| Vol 18, No 4 (2011) | A comprehensive bone health management approach for men with prostate cancer receiving androgen deprivation therapy | Abstract PDF HTML |
| C.E. Lee, W.D. Leslie, P. Czaykowski, J. Gingerich, M. Geirnaert, Y.K.J. Lau | ||
| Vol 16, No 1 (2009) | A Framework for the Organization and Delivery of Systemic Treatment | Abstract PDF |
| Ted Vandenberg, Nadia Coakley, Jeff Naylor, Cathy DeGrasse, Esther Green, Jean A Mackay, Cynthia McLennan, Anne Smith, Laura Wilcock, Maureen E Trudeau | ||
| Vol 18, No 5 (2011) | A legal right to die: responding to slippery slope and abuse arguments | Details PDF HTML |
| D. Benatar | ||
| Vol 19, No 1 (2012) | A model for breast cancer risk based on stem-cell theory | Abstract PDF HTML |
| S. A. Narod | ||
| Vol 18, No 3 (2011) | A multicentre open-label safety and efficacy study of tetrodotoxin for cancer pain | Abstract PDF HTML |
| N. A. Hagen, B. Lapointe, M. Ong-Lam, B. Dubuc, D. Walde, B. Gagnon, R. Love, R. Goel, P. Hawley, A. Ho Ngoc, P. du Souich | ||
| Vol 18, No 2 (2011) | A new standard of care for the management of peritoneal surface malignancy | Abstract PDF HTML |
| F. Mohamed, T. Cecil, B. Moran, P. Sugarbaker | ||
| Going Beyond Efficacy | A Primer of Bone Metastases Management in Breast Cancer Patients | Abstract PDF |
| Mark Clemons, Bianca Petrut, Mateya Trinkaus, Christine Simmons | ||
| Vol 18, No 6 (2011) | A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy | Abstract PDF HTML |
| A. Robidoux, E. Rich, N.J. Bureau, S. Mader, D. Laperrière, M. Bail, N. Tremblay, J. Turgeon, M. Patenaude | ||
| Vol 17, No 5 (2010) | A rare adverse skin reaction after 8 Gy of radiation therapy to the thoracic spine: case report and review of the literature | Abstract PDF |
| G. Mitera, G. Chan, K. Mah, R. Law, C. DeAngelis, R. Dent, E. Chow | ||
| Vol 17, No 2 (2010) | A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital | Abstract PDF |
| S. N. Chin, L. Wang, M. Moore, S. S. Sridhar | ||
| Vol 16, No 1 (2009) | A Review of the Reliability and Validity of the Edmonton Symptom Assessment System | Abstract PDF |
| Lyndsay A Richardson, Glenn W Jones | ||
| Vol 18, No 4 (2011) | A single-centre chart review exploring the adjusted association between breast cancer phenotype and prognosis | Abstract PDF HTML |
| C. Hamm, M. El-Masri, G. Poliquin, V. Poliquin, J. Mathews, S. Kanjeekal, Y. Alam, S. Kulkarni, T. Elfiki | ||
| Vol 14, No 2 (2007) | A Tale of Two Time Periods: Ovarian Cancer Trends in Ontario | Abstract PDF |
| Laurie M Elit, Susan J Bondy, Zhongliang Chen, Lawrence Paszat | ||
| Vol 12, No 4 (2005) | Access to radiation therapy: modeling the geographic distribution of demand | Details PDF |
| Michael R Taylor, Peter S Craighead, Peter B Dunscombe | ||
| Vol 17, No 4 (2010) | Access to thalidomide for the treatment of multiple myeloma in Canada: physician behaviours and ethical implications | Abstract PDF |
| L. Minuk, R. Sibbald, J. Peng, S. Bejaimal, I. Chin-Yee | ||
| Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective | Active surveillance for prostate cancer: patient selection and management | Abstract PDF |
| L. Klotz | ||
| Vol 18, No 2 (2011) | Acute aortic thrombosis in patients receiving cisplatin-based chemotherapy | Abstract PDF HTML |
| D. D. Fernandes, M. L. Louzada, C. A. Souza, F. Matzinger | ||
| Vol 18, No 1 (2011) | Acute liver failure because of chronic lymphocytic leukemia: case report and review of the literature | Abstract PDF HTML |
| K. Esfahani, P. Gold, S. Wakil, R. P. Michel, S. Solymoss | ||
| Vol 14, No 2 (2007) | Addition of Lenalidomide to Melphalan in the Treatment of Newly Diagnosed Multiple Myeloma: The NCIC CTG MY.11 Trial | Details PDF |
| Darrell White, Nancy Paul, David A Macdonald, Ralph M Meyer | ||
| Vol 16 (2009): Renal Cell Carcinoma Supplement | Adjuvant and Neoadjuvant Small Molecule Targeted Therapy | Abstract PDF |
| Anil Kapoor | ||
| Vol 17, No 4 (2010) | Adjuvant chemoradiation for gastric cancer with infusional 5-fluorouracil and cisplatin: a phase I study | Abstract PDF |
| Z. Kassam, H. Mackay, C.A. Buckley, S. Fung, M. Pintile, A. Oza, J. Brierley, C. Swallow, B. Cummings, J.J. Knox, J. Kim, R. Wong, L. Siu, R. Feld, J. Ringash | ||
| Vol 15, No 3 (2008) | Adjuvant Hormonal Therapy for Stage I Endometrial Cancer | Details PDF |
| Lilian Gien, Janice S Kwon, Thomas K Oliver, Michael Fung-Kee-Fung | ||
| Vol 17, No 3 (2010) | Adjuvant interferon alfa for melanoma | Abstract PDF |
| K. S. Wilson, A. Attwell | ||
| Vol 16, No 3 (2009) | Adjuvant Interferon alfa for melanoma: new evidence-based treatment recommendations? | Abstract PDF |
| Axel Hauschild | ||
| Vol 13, No 1 (2006) | Adjuvant trastuzumab: progress, controversies, and the steps ahead | Details PDF |
| John Mackey, Anil A Joy | ||
| Vol 17 (2010): Optimal management of metastatic colorectal cancer with the anti-EGFR monoclonal antibodies | Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer | Abstract PDF |
| M. Fakih, M. Vincent | ||
| Vol 14, No 3 (2007) | Alemtuzumab in Chronic Lymphocytic Leukemia: A Systematic Review and Clinical Practice Guideline | Details PDF |
| Christopher A Smith | ||
| Vol 18, No 2 (2011) | An appraisal of life’s terminal phases and euthanasia and the right to die | Details PDF HTML |
| L. Z.G. Touyz, S. J.J. Touyz | ||
| Vol 15, No 2 (2008) | An Approach to the Management of Chronic Myeloid Leukemia in British Columbia | Details PDF |
| Donna Lynn Forrest, X Jiang, C Eaves, C Smith | ||
| Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective | AN INTEGRATED SUPPORT AND INFORMATION CENTRE IN A LARGE UK CANCER CENTRE ESTABLISHED IN 1993 & REPLICATED IN MORE THAN 60 UNITS ACROSS THE UK AND AUSTRALIA. | Abstract PDF |
| Jane Maher | ||
| Vol 16 (2009): Endocrine Therapy Update Supplement | An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor–positive early breast cancer | Abstract PDF |
| S. Verma, S. Sehdev, A Joy, Y. Madarnas, J. Younus, J. A. Roy | ||
| Vol 15, No 5 (2008) | Anal Cancer and Human Papillomaviruses in Heterosexual Men | Abstract PDF |
| Alan Nyitray | ||
| Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective | Androgen deprivation therapy for prostate cancer—review of indications in 2010 | Abstract PDF |
| H. Quon, D.A. Loblaw | ||
| Vol 14, No 6 (2007) | Anemia is a common but neglected complication of adjuvant chemotherapy for early-stage breast cancer | Details PDF |
| Amanda Goldrick, Ivo A Olivotto, Cheryl Alexander, Caroline H Speers, Jeff Barnett, Sharon J Allan, Pauline T Truong | ||
| Vol 17, No 4 (2010) | Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme | Abstract PDF |
| J. Oh, G.J. Kutas, P. Davey, M. Morrison, J.R. Perry | ||
| Vol 17, No 1 (2010) | Application of machine learning methodology for PET-based definition of lung cancer | Abstract PDF |
| A. Kerhet, C. Small, H. Quon, T. Riauka, L. Schrader, R. Greiner, D. Yee, A. McEwan, W. Roa | ||
| Vol 15, No 4 (2008) | Are Matrix Metalloproteinases Relevant Therapeutic Targets for Prostate Cancer Bone Metastasis? | Abstract PDF |
| R. Daniel Bonfil, Rafael Fridman, Shahriar Mobashery, Michael L. Cher | ||
| Vol 18, No 5 (2011) | Array comparative genomic hybridization and cytogenetic analysis in pediatric acute leukemias | Abstract PDF HTML |
| A. J. Dawson, R. Yanofsky, R. Vallente, S. Bal, I. Schroedter, L. Liang, S. Mai | ||
| Vol 17, No 6 (2010) | Arterial embolization for ruptured adrenal pheochromocytoma | Abstract PDF |
| M. Habib, I. Tarazi, M. Batta | ||
| Vol 17, No 6 (2010) | Arterial occlusion precipitated by cisplatin-based chemotherapy | Abstract PDF |
| D. Joseph, B. Dubashi, B. Karthikeyan, A. Jain | ||
| Vol 18, No 6 (2011) | Assessment and management of febrile neutropenia in emergency departments within a regional health authority—a benchmark analysis | Abstract PDF HTML |
| D. Szwajcer, P. Czaykowski, D. Turner | ||
| Vol 17, No 5 (2010) | Association of lipid metabolism with ovarian cancer | Abstract PDF |
| M. Tania, M.A. Khan, Y. Song | ||
| Vol 18, No 6 (2011) | Author Index | Abstract PDF HTML |
| Current Oncology | ||
| Vol 13, No 1 (2006) | Awareness and Use of the Rapid Palliative Radiotherapy Program by Family Physicians in Eastern Ontario: A Survey | Details PDF |
| E J Fitzgibbon | ||
| 1 - 50 of 514 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Copyright © 2012 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)